SOMAVERT

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug SOMAVERT contains one active pharmaceutical ingredient (API):

1	Pegvisomant UNII N824AOU5XV - PEGVISOMANT
	Pegvisomant is an analogue of human growth hormone that has been genetically modified to be a growth hormone receptor antagonist for the treatment of adult patients with acromegaly. Pegvisomant is highly selective for the GH receptor, and does not cross-react with other cytokine receptors, including prolactin.
	Read more about Pegvisomant

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SOMAVERT Powder and solvent for solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01AX01	Pegvisomant	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AX Other anterior pituitary lobe hormones and analogues
Discover more medicines within H01AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11166Q, 11167R, 11172B, 11173C, 11174D, 11177G, 11179J, 11181L
BR	Câmara de Regulação do Mercado de Medicamentos	522720050085917, 522720050086017, 522720050086117, 522720050086217, 522720050086317, 522720050086417, 522720050086517, 522721100090307, 522721100090407
CA	Health Products and Food Branch	02272199, 02272202, 02272210, 02448831, 02448858
EE	Ravimiamet	1196995, 1197008, 1197019, 1197020, 1709771, 1709782, 1709793, 1709805
ES	Centro de información online de medicamentos de la AEMPS	02240001, 02240002, 02240003, 102240010, 102240012
FI	Lääkealan turvallisuus- ja kehittämiskeskus	126868, 142410, 532072, 540527, 588227
FR	Base de données publique des médicaments	66553998, 67096189, 69108170
GB	Medicines & Healthcare Products Regulatory Agency	324177, 324180, 75435, 75439, 75443, 78464
IE	Health Products Regulatory Authority	88854, 88855, 88856, 88857
IL	מִשְׂרַד הַבְּרִיאוּת	6058, 6059, 6060, 8089, 8090, 8164, 8165, 8166
IT	Agenzia del Farmaco	035726013, 035726025, 035726037, 035726049, 035726052, 035726064, 035726076, 035726088
JP	医薬品医療機器総合機構	2499409D1022, 2499409D2029, 2499409D3025
LT	Valstybinė vaistų kontrolės tarnyba	1030814, 1030815, 1030816, 1030817, 1081289, 1081290, 1081291, 1081292
NL	Z-Index G-Standaard, PRK	129720, 129723, 129739, 70491, 70505, 70513
PL	Rejestru Produktów Leczniczych	100126643, 100126650, 100126666, 100388745, 100388751
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64864001, W64865001
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308278746, 8681308278753, 8681308278760